Baird Financial Group
UTHR icon

Baird Financial Group’s United Therapeutics UTHR Stock Holding History

Baird Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,778
Closed -$2.07M – 1816
2024
Q3 		$2.07M Buy
+5,778
New +$1.95M ﹤0.01% 953
2019
Q3 		– Sell
-10,602
Closed -$828K – 1556
2019
Q2 		$828K Sell
10,602
-21,224
-67% -$1.98M ﹤0.01% 1051
2019
Q1 		$3.73M Sell
31,826
-147
-0.5% -$17.1K 0.02% 513
2018
Q4 		$3.48M Sell
31,973
-3,189
-9% -$370K 0.02% 494
2018
Q3 		$4.43M Buy
35,162
+728
+2% +$90K 0.03% 474
2018
Q2 		$3.9M Sell
34,434
-83
-0.2% -$9.12K 0.03% 488
2018
Q1 		$3.88M Buy
34,517
+4,498
+15% +$571K 0.03% 471
2017
Q4 		$4.44M Buy
30,019
+229
+0.8% +$29.1K 0.03% 442
2017
Q3 		$3.49M Buy
29,790
+1,128
+4% +$144K 0.03% 490
2017
Q2 		$3.72M Buy
28,662
+2,284
+9% +$285K 0.03% 465
2017
Q1 		$3.57M Sell
26,378
-511
-2% -$77.4K 0.03% 468
2016
Q4 		$3.86M Buy
26,889
+3,981
+17% +$508K 0.03% 428
2016
Q3 		$2.71M Buy
22,908
+4,766
+26% +$573K 0.02% 494
2016
Q2 		$1.92M Buy
18,142
+8,005
+79% +$893K 0.02% 560
2016
Q1 		$1.13M Sell
10,137
-348
-3% -$44K 0.01% 686
2015
Q4 		$1.64M Sell
10,485
-1,403
-12% -$204K 0.02% 576
2015
Q3 		$1.56M Buy
11,888
+686
+6% +$110K 0.02% 583
2015
Q2 		$1.95M Buy
+11,202
New +$2.02M 0.02% 557

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Baird Financial Group's UTHR Position: Q4 2024 in Review

Baird Financial Group sold out of United Therapeutics (UTHR) in Q4 2024, closing a stake of 5,778 shares — an estimated $2.07M sold.

Baird Financial Group first reported a position in UTHR in Q2 2015 and held it in 18 quarters. The position peaked at $4.44M in Q4 2017. 672 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • Baird Financial Group reported no remaining United Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 5,778 United Therapeutics shares in Q4 2024, an estimated $2.07M.
  • Baird Financial Group first reported a position in United Therapeutics in Q2 2015 and held it in 18 quarters.
  • Baird Financial Group's United Therapeutics position peaked at $4.44M in Q4 2017.
  • 672 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.